Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
430.85
Change Change %
-13.25 -2.98%

Updated:27 May, 2020, 15:55 PM IST

BSE
431.05
Change Change %
-14.90 -3.34%

Updated:27 May, 2020, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
HDFC Securities
N/A
24-12-2018 Buy 710.00 980.00
N/A
Closed Medium (6M)
24-01-2019

HDFC Securities Recommends 'Buy' On Jubilant Life Sciences

According to HDFC Securities, there are several tailwinds that will ensure profitability for Jubilant Life Sciences, including a strong product pipeline and a rain in market share in venoms and radio pharma. Additionally, the planned IPO for subsidiary is expected to lead to significant debt reduction for the company, the brokerage adds.

Top
Listen to the latest songs, only on JioSaavn.com